UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030362
Receipt number R000034667
Scientific Title Establishment of neurocognitive training to improve frontal lobe function in moyamoya disease
Date of disclosure of the study information 2017/12/12
Last modified on 2020/02/17 14:57:02

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Establishment of neurocognitive training to improve frontal lobe function in moyamoya disease

Acronym

Establishment of neurocognitive training to improve frontal lobe function in moyamoya disease

Scientific Title

Establishment of neurocognitive training to improve frontal lobe function in moyamoya disease

Scientific Title:Acronym

Establishment of neurocognitive training to improve frontal lobe function in moyamoya disease

Region

Japan


Condition

Condition

moyamoya disease

Classification by specialty

Radiology Neurosurgery Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the changes in neuropsychological test performance, and the morphological and functional changes of the brain, following neurocognitive training in moyamoya disease patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Percentage of correct answers in the PASAT score before and after the neurocognitive training and the magnitude of change in the scores

Key secondary outcomes

1.Pre- and post-neurocognitive training neuropsychological test results (trail making test part A and B, digit span test, tapping span test, standard verbal paired-associate learning test scores)and the magnitude of change
2.Pre- and post-training morphological and functional imaging results and the magnitude of change
3.Correlation between the morphological and functional imaging results and the neuropsychological performance (the magnitude of change in each score before and after training)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Other

Interventions/Control_1

Neurocognitive training
1 hour/session, 5 sessions/week for 4 weeks, a total of 20 hours

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

65 years-old >=

Gender

Male and Female

Key inclusion criteria

1.Patients between 20 and 65 years of age at the time of consent
2.Those who were diagnosed as moyamoya disease according to the guidelines of MMD proposed by the Research Committee on spontaneous occlusion of the circle of Willis
3.Those patients who gave informed consent based on own will or the will of a guardian

Key exclusion criteria

1.Quasimoyamoya syndrome with conditions such as Down syndrome and neurofibromatosis
2.Stroke with neurological deficit
3.Psychological or neurological disorders which affect the neuropsychological test performance
4.Vision or hearing impairment or motor disability which affects the neuropsychological test performance
5.Contraindications for MRI (cardiac pacemaker, inner ear implant, claustrophobia, etc)
6.Revascularization surgery before the study
7.Conditions in which the principal investigator considers not suitable for participation in the study

Target sample size

21


Research contact person

Name of lead principal investigator

1st name Khin Khin
Middle name
Last name Tha

Organization

Hokkaido University Hospital

Division name

Department of diagnostic and interventional radiology

Zip code

060-8648

Address

Kita14, Nishi5, Kita-ku, Sapporo

TEL

011-706-5977

Email

kktha@med.hokudai.ac.jp


Public contact

Name of contact person

1st name Daisuke
Middle name
Last name Sawamura

Organization

Hokkaido University

Division name

Graduate School of Biomedical Science and Engineering

Zip code

060-0812

Address

Kita14, Nishi5, Kita-ku, Sapporo

TEL

011-706-8183

Homepage URL


Email

dai-sawa@hoku-iryo-u.ac.jp


Sponsor or person

Institute

Hokkaido University Hospital,
Department of diagnostic and interventional radiology

Institute

Department

Personal name



Funding Source

Organization

Hokkaido University Hospital,
Department of diagnostic and interventional radiology

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Institutional Review Board of Hokkaido University Hospital

Address

kita-14, nishi-5, Kita-ku

Tel

011-706-7636

Email

crjimu@huhp.hokudai.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 12 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2017 Year 12 Month 12 Day

Date of IRB

2017 Year 12 Month 14 Day

Anticipated trial start date

2017 Year 12 Month 19 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 12 Month 12 Day

Last modified on

2020 Year 02 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000034667


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name